The conjugation of VEGFR-1 ligand and fluorescent PEGylated peptide on CPMV NPs can target VEGFR-1 on endothelial cell lines and VEGFR1-expressing tumor xenografts in vivo [57]. Here, FLT1 is linked to neoplasm.